Q32 Bio Inc. (SWB:DB0) IPO
IPO
Went public as Homology Medicines, Inc. Priced at US$16.00 a share on Mar 27, 2018.
- Price
- US$16.00 a share
- Shares offered
- 9,000,000 shares of common stock
- Offering size
- US$144 million
- Underwriters' option
- Up to 1,350,000 more shares
- Underwriters
- BofA Merrill Lynch, Cowen, Evercore ISI, BTIG · In the order on the cover
- Shares delivered
- On or about Apr 2, 2018
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 22, 2017 |
| Filed publicly | Mar 2, 2018 |
| Amended 3 times | Newest Mar 27, 2018 |
| Shares registered with an exchange | Mar 19, 2018 |
| Declared effective by the SEC | Mar 27, 2018 |
| Final prospectus, with the price | Mar 29, 2018 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 29, 2018 |
| EFFECT · Notice that a registration is effective | Mar 27, 2018 |
| FWP · Free writing prospectus | Mar 27, 2018 |
| S-1/A · Registration statement, amended | Mar 27, 2018 |
| CORRESP · Letter to the SEC | Mar 23, 2018 |
| CORRESP · Letter to the SEC | Mar 23, 2018 |
| S-1/A · Registration statement, amended | Mar 23, 2018 |
| CERT · Exchange's certificate of listing | Mar 22, 2018 |
| S-1/A · Registration statement, amended | Mar 19, 2018 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 19, 2018 |
| CORRESP · Letter to the SEC | Mar 14, 2018 |
| UPLOAD · Letter from the SEC | Mar 6, 2018 |
| S-1 · Registration statement | Mar 2, 2018 |
| DRSLTR · Letter to the SEC with a draft | Feb 23, 2018 |
| DRS/A · Draft registration statement, amended | Feb 23, 2018 |
| UPLOAD · Letter from the SEC | Feb 12, 2018 |
| DRSLTR · Letter to the SEC with a draft | Jan 30, 2018 |
| DRS/A · Draft registration statement, amended | Jan 30, 2018 |
| UPLOAD · Letter from the SEC | Jan 19, 2018 |
| DRS · Draft registration statement | Dec 22, 2017 |
From the cover of the final prospectus (424B4) filed Mar 29, 2018